Twist Bioscience Corp (TWST) — Financial Flexibility Index
Twist Bioscience Corp (TWST) has a Financial Flexibility Index of 0.05x as of June 2026. Free cash flow of $10.78 Million (operating CF $1.11 Million minus capex $9.66 Million) represents 0% of total liabilities ($226.70 Million). Check Twist Bioscience Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Twist Bioscience Corp Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Twist Bioscience Corp across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Twist Bioscience Corp.
Annual Financial Flexibility Index for Twist Bioscience Corp (2016–2025)
Year-by-year free cash flow to debt coverage for Twist Bioscience Corp. Explore Twist Bioscience Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-19.62 Million | $-47.63 Million | $168.90 Million | ▲ +72.1% |
| 2024 | -0.42x | $-59.02 Million | $-64.09 Million | $141.63 Million | ▲ +44.4% |
| 2023 | -0.75x | $-114.69 Million | $-142.47 Million | $152.97 Million | ▼ -472.4% |
| 2022 | -0.13x | $-22.53 Million | $-124.39 Million | $171.99 Million | ▲ +81.4% |
| 2021 | -0.70x | $-85.18 Million | $-112.24 Million | $121.28 Million | ▲ +66.8% |
| 2020 | -2.11x | $-132.39 Million | $-142.25 Million | $62.62 Million | ▼ -0.9% |
| 2019 | -2.10x | $-73.18 Million | $-87.94 Million | $34.91 Million | ▼ -964.3% |
| 2018 | -0.20x | $-62.48 Million | $-66.16 Million | $317.21 Million | ▲ +3.5% |
| 2017 | -0.20x | $-44.71 Million | $-51.30 Million | $219.01 Million | ▲ +3.4% |
| 2016 | -0.21x | $-32.36 Million | $-38.59 Million | $153.07 Million | — |